Compass Pathway's Dr. Steve Levine

Update: 2025-07-21

Description

Fresh from Psychedelic Science 2025, Dr. Steve Levine, the chief patient officer at Compass Pathways, talks to us about new Phase 3 results for psilocybin in treating depression.

Comments

In Channel

Compass Pathway's Dr. Steve Levine

2025-07-2151:25

Dreaming (part 3) with Antti Revonsuo

2025-01-2801:36:52

Dreams and Anaesthesia: Guest Pilleriin Sikka

2024-11-2644:05

Autism with guest Matthew Goodwin

2024-01-2501:05:04

Donald Hoffman's Case Against Reality

2024-01-0844:24

Why do we dream?

2024-11-0847:33

AI and Cognition with Daniel Sternberg

2024-03-2501:21:50

Episode 53: Beckley Retreats CEO Neil Markey on guided psychedelic retreats

2023-12-2256:20

Episode 52: The IIT controversy with Felipe De Brigard

2023-11-2901:09:22

Episode 51: Robin Carhart-Harris: The promise of psychedelics

2023-10-1602:03:45

Episode 50: Neural Interfaces

2023-09-2031:01

Episode 49: The Self: Bundle and Ego Theories

2023-08-1653:31

Episode 48: Psychedelic Science 2023

2023-07-1801:35:11

Episode 47: Street Epistemology with Mark Solomon

2023-06-1352:41

Episode 46: Manesh Girn: Psychedelics and Brain Networks

2023-05-0155:28

Episode 45: Blame and Political Attitudes: Gail Sahar

2023-04-1201:00:38

Episode 44: Daniel Sternberg: The State of Artificial Intelligence

2023-02-1501:22:16

Episode 43: Stephanie Preston: Our Attachment to Stuff

2022-12-2001:00:03

Episode 42: The Science of Sleep with Dr. Aric Prather

2022-11-2801:13:05

Episode 41: The Marshmallow Test

2022-09-2149:28

00:00

Compass Pathway's Dr. Steve Levine

#box-pro-ellipsis-176606982279213{-webkit-line-clamp:2;}Compass Pathway's Dr. Steve Levine

Compass Pathway's Dr. Steve Levine

Joe Hardy

Compass Pathway's Dr. Steve Levine